Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply.

Colhoun, Helen M; McGurnaghan, Stuart J; McKeigue, Paul M

Colhoun, Helen M; McGurnaghan, Stuart J; McKeigue, Paul M.

Colhoun HM; Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK; Public Health Scotland, Glasgow, UK. Electronic address: helen.colhoun@igmm.ed.ac.uk.
McGurnaghan SJ; Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK; Public Health Scotland, Glasgow, UK.
McKeigue PM; Public Health Scotland, Glasgow, UK; Usher Institute College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.

Lancet Diabetes Endocrinol ; 9(4): 201, 2021 04.

Article in English | MEDLINE | ID: covidwho-1142355

Subject(s)

COVID-19; Diabetes Mellitus; Cohort Studies; Humans; Risk Factors; SARS-CoV-2; Scotland

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: Lancet Diabetes Endocrinol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google